Impact of Coronary Calcification on Complete Revascularization in Patients With Acute Coronary Syndrome and Multivessel Disease
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31495 ↗At a glance
Randomisierte kontrollierte Studie in Catheterization and Cardiovascular Interventions, 2025. Written by William Camilleri and 10 co-authors. Institution: Department of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands. Major MEDLINE topics: Acute Coronary Syndrome, Vascular Calcification, Coronary Artery Disease, Percutaneous Coronary Intervention. 21 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Coronary calcification is a well‐known marker of atherosclerotic plaque burden and a determinant of stent under expansion with unfavorable long‐term outcomes.
Aims
This sub study of the randomized BIOVASC trial aimed to compare immediate complete revascularization (ICR) and staged complete revascularization (SCR) in patients with acute coronary syndrome (ACS) and multi vessel disease (MVD), stratified by calcification of the culprit lesion.
Methods
The primary endpoint consisted of a composite of all‐cause mortality, myocardial infarction, unplanned ischemia driven revascularization (UIDR) and cerebrovascular events at 2 year follow‐up. Secondary endpoints included the individual components of the primary composite and major bleedings. We used cox regression models to relate study endpoints with randomized treatment stratified by calcification of the culprit lesion.
Results
The BIOVASC trial enrolled 103 patients with a moderately or severely calcified culprit lesion. The composite primary outcome occurred in 8/57 (14.3%) versus 9/46 (19.7%) patients randomized to ICR and SCR (hazard ratio [HR] 0.66% and 95% confidence interval [CI] 0.25−1.71, p = 0.39). In the non‐calcified culprit lesions, there were 83 events in the ICR (12.4%) and 82 events in the SCR (11.9%) (HR 1.01 [0.75−1.37], p = 0.94, P‐interaction = 0.42). There was no evidence of a differential effect of ICR vs. SCR on the primary endpoint in relation to culprit lesion calcification (P‐interaction = 0.42).
Conclusion
No differential treatment effect of ICR versus SCR was observed when comparing the primary composite outcome between calcified and non‐calcified culprit lesion.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
ORCID profiles: William Camilleri, Jacob J Elscot, Nicolas M Van Mieghem, Roberto Diletti, Joost Daemen
Cite
APA
Camilleri, W., Kakar, H., Elscot, J. J., Boersma, E., Van Mieghem, N. M., Diletti, R., Daemen, J., Ntantou, E., Wilschut, J., Jan Nuis, R., & Den Dekker, W. K. (2025). Impact of Coronary Calcification on Complete Revascularization in Patients With Acute Coronary Syndrome and Multivessel Disease. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31495
Vancouver
Camilleri W, Kakar H, Elscot JJ, Boersma E, Van Mieghem NM, Diletti R, et al. Impact of Coronary Calcification on Complete Revascularization in Patients With Acute Coronary Syndrome and Multivessel Disease. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31495
BibTeX
@article{Camilleri2025,
author = {Camilleri, William and Kakar, Hala and Elscot, Jacob J and Boersma, Eric and Van Mieghem, Nicolas M and Diletti, Roberto and Daemen, Joost and Ntantou, Elena and Wilschut, Jeroen and Jan Nuis, Rutger and Den Dekker, Wijnand K},
title = {Impact of Coronary Calcification on Complete Revascularization in Patients With Acute Coronary Syndrome and Multivessel Disease},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31495}
}
EUVIMED